Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.54

-0.48

-0.42

-0.36

Details

Expected EPS

-0.543275

Actual EPS

-0.54

Surprise EPS

0

Surprise Percent

+0.6%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.54 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.